NIH Expands Network Focused on How Genes Affect Drug Responses 09 September 2010 NIH plans to spend $161.3 million over the next five years to expand the Pharmacogenomics Research Network.
BioFocus and Usher III Initiative, Inc. Announce Collaboration 09 September 2010 Under the agreement, BioFocus will perform an integrated program encompassing medicinal chemistry and biological sciences.
Roche and reMYND Enter Agreement to Develop First-in-Class Disease-Modifying Treatments for Parkinson’s and Alzheimer’s Disease 07 September 2010 Novel therapies to target unmet needs in neurodegenerative disorders.
Novozymes Announces Master File for Recombinant Albumin 03 September 2010 The dossier, containing information on the manufacture and safety of albucult, can help support the medical devices and drug formulation applications.